PacificHealth Laboratories, Inc. (OTCBB: PHLI), a leading sports nutrition company, today reported its financial results for the quarter and six months ended June 30, 2010.
“We also launched our new single serve sachets beginning in June into the sports specialty channel which we expect to continue to drive trial as well as allow our loyal consumers an easy take along sachet for their endurance activity.”
Second Quarter 2010 vs. Second Quarter 2009 Financial Results
Revenues were $2,554,306 compared to $2,725,055 for the same period in 2009. Net income for the second quarter of 2010 increased to $136,725, or $0.01 per diluted share, from net income of $12,922, or $0.00 per diluted share, for the same period in 2009. In the second quarter of 2009, as a result of a change in estimate relating to revenue recognition in connection with sales to a major customer, the Company recognized additional revenues of approximately $279,000. Had the Company not recorded these additional revenues, revenues would have increased $108,251 (or approximately 4%, non-GAAP measure) for the second quarter of 2010 as compared to the same period in 2009. Sales and marketing expenses decreased $105,642, or 23%, in the second quarter of 2010 as compared to the same period in 2009. General and administrative ("G & A") expenses decreased $84,576, or 10% in the second quarter of 2010 as compared to the same period in 2009. Included in G & A in the second quarter of 2010 and 2009 is approximately $104,000 and $74,000, respectively, paid to former CEO's in the form of non-compete clauses pursuant to Separation Agreements. Had the Company not incurred these Separation expenses, net income for the second quarter of 2010 would have been approximately $241,000, or $0.02 per share (non-GAAP measure) compared to net income for the second quarter of 2009 of approximately $87,000, or $0.01 per share (non-GAAP measure).
At June 30, 2010, the Company had cash, cash equivalents, and other short-term investments of $757,000 as compared to $426,000 at March 31, 2010 and $456,000 at December 31, 2009.
"Our focus on the core endurance nutrition business is beginning to show positive financial results. We were able to increase shipments in dollars in the quarter by 4%, reflecting increased consumption while continuing to keep our expenses down year over year, resulting in net income growth of over 10 times from a year ago," said Fred Duffner, President of PacificHealth Laboratories. "We also launched our new single serve sachets beginning in June into the sports specialty channel which we expect to continue to drive trial as well as allow our loyal consumers an easy take along sachet for their endurance activity."
First Half 2010 Financial Results vs. First Half 2009 Financial Results
Revenue was $4,204,571 compared to $4,420,673 for the same period in 2009. Net loss for the first half of 2010 was $132,505, or $0.01 per diluted share, compared to a net loss of $392,543, or $0.03 per diluted share, for the same period in 2009. In the first six months of 2009, as a result of a change in estimate relating to revenue recognition in connection with sales to a major customer, the Company recognized additional revenues of approximately $279,000. Had the Company not recognized these additional revenues, revenues would have increased $62,898 (or approximately 2%, non-GAAP measure) for the first six months of 2010 as compared to the same period in 2009. Sales and marketing expenses decreased $186,665, or 24%, in the first six months of 2010 as compared to the same period in 2009. General and administrative expenses decreased $142,908, or 9%, in the first six months of 2010 compared to the same period in 2009. Included in G & A in the first six months of 2010 and 2009 is approximately $173,000 and $147,000, respectively, paid to former CEO's in the form of non-compete clauses pursuant to Separation Agreements. Had the Company not incurred these Separation expenses, the Company would have recorded a net income for the first six months of 2010 of approximately $40,000, or $0.00 per share (non-GAAP measure) compared to a net loss for the six months of 2009 of approximately $246,000, or $0.02 per share (non-GAAP measure).
Mr. Duffner concluded, "We have made great strides increasing shipments, reducing expenses, and building our cash position in the first half of 2010. The emphasis on building our core business has helped eliminate incremental costs associated with our weight management brand FORZE GPS™ from a year ago. The Company has also reduced inventory levels and G&A costs, allowing us to build our cash position and to show positive financial results from a year ago."
Biomarkers of food intake: The key to precision nutrition